Schall, Brown & Schwartz LLP reminded investors of an ongoing class action lawsuit against Capricor Therapeutics (NASDAQ: CAPR) alleging violations of §§10(b) and 20(a). The filing is a legal overhang and may increase downside risk for shareholders, though no financial impact or case outcome is provided in the note.
Schall, Brown & Schwartz LLP reminded investors of an ongoing class action lawsuit against Capricor Therapeutics (NASDAQ: CAPR) alleging violations of §§10(b) and 20(a). The filing is a legal overhang and may increase downside risk for shareholders, though no financial impact or case outcome is provided in the note.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
